Evernow Review: The $35 Membership Costs $420 Up Front

For the membership: $49 a month if you pay monthly, $129 for three months, or $420 for twelve — the last two charged in a single payment at the start. For a video visit, either your insurance copay or $150 self-pay, on top of the membership. For the medication, nobody outside the sign-in knows: Evernow publishes no drug price anywhere on its public site. The single exception is vaginal estradiol cream, which is included at no extra charge on the three- and twelve-month plans. Read off evernow.com on August 9, 2026.

From the annual plan, divided by twelve. Evernow's FAQ lists all three tiers together — "Month-to-month plan: $49 a month. 3-month plan: $129 for 3 months of Evernow ($43 a month). 12-month plan: $420 for 12 months of Evernow ($35 a month)" — so the arithmetic is honest where it is stated. The problem is where it is not: "Starts at $35/month" appears on the homepage and on every treatment page on the site, and none of them mentions $420 or the word annual. Since Evernow "does not provide refunds for members after they engage with their provider", someone who joins at the advertised rate and leaves after a month has paid $420 for that month.

No, and Evernow repeats it on every care page: "The cost of any medications you are prescribed at Evernow are not included but may be covered by insurance when filled through your local pharmacy." Its FAQ explains the reasoning — keeping visits and medications outside the membership lets it "offer you competitive prices for only the services you need" — which is a defensible model. What makes it hard to price is that Evernow then publishes no medication prices at all. Every drug page on its own commerce app is behind a sign-in, so the only way to learn what a month of hormone therapy costs is to become a member first.

Yes, with two conditions Evernow states plainly. Its Terms say membership "include[s] optional, complimentary access to vaginal estradiol cream, if determined medically appropriate by their… Provider for members on quarterly or annual plans", and the product page repeats it as "Get FREE vaginal estrogen cream* (worth up to $480/year) with a multi-month membership *Must medically qualify and be on a 3-or-12-month plan". So it is not available on the $49 month-to-month plan, and it depends on a clinician agreeing it suits you. If both hold, $129 for three months is the cheapest all-in route to a vaginal estrogen cream on this site — $43 a month with care and the medicine in one bill.

Yes, and it names them: "Medications such as Ozempic® (semaglutide), Wegovy® (semaglutide), Rybelsus® (semaglutide), Mounjaro® (tirzepatide), Zepbound® (tirzepatide), and Contrave® (naltrexone-bupropion) are available." What it does not do is price any of them — every weight-loss page carries the $35 membership card and no drug figure, and the medication pages on its commerce app are sign-in gated. That is why this review carries no GLP-1 row and why Evernow appears on none of our GLP-1 boards: a price nobody publishes cannot be ranked, and inventing one is the failure this site exists to prevent. One undated page also still claims "We offer compounded versions of GLP-1 medications", which no other page on the site supports.

Two, and both are on the commerce app rather than the marketing site. A video visit is $150 self-pay if your insurance does not cover it, charged on top of the membership — Evernow addresses the stacking head-on in a FAQ headed "Why do I have a membership cost in addition to a video visit or medications?". And "if you cancel a video visit in less than 24 hours of your scheduled visit time (or do not attend your visit), you will be charged a $50 fee". Neither is part of a subscription cycle, so neither has been added to the prices above, but both are real money.

No. The live warning-letter index was queried on August 9, 2026 under "evernow", which returned zero rows with the returned count matching the filtered count, and under the spaced "ever now", which returned 74 rows — all of them returned in full rather than paged, and every one re-checked against the company column. They are seafood processors, supplement makers, device manufacturers and two Eli Lilly letters, caught on ordinary words in the letter body; Evernow, Inc. is in none of them and nothing has been filed on a name resemblance. The screen ran with a positive control that returned SkinnyRx's February 2026 letter and a close-out control on Belmar Pharma Solutions, so the absence is a finding rather than a broken query.